Research ArticleSpecial Section on Epigenetic Regulation of Drug Metabolizing Enzymes and Transporters
Regulation of MicroRNA Expression by Rifampin in Human Hepatocytes
Anuradha Ramamoorthy, Yunlong Liu, Santosh Philips, Zeruesenay Desta, Hai Lin, Chirayu Goswami, Andrea Gaedigk, Lang Li, David A. Flockhart and Todd C. Skaar
Drug Metabolism and Disposition October 2013, 41 (10) 1763-1768; DOI: https://doi.org/10.1124/dmd.113.052886
Anuradha Ramamoorthy
Department of Medicine, Division of Clinical Pharmacology (A.R., S.P., Z.D., D.A.F., T.C.S.), and Department of Medical and Molecular Genetics (A.R., Y.L., H.L., C.G., L.L.), Indiana University School of Medicine, Indianapolis, Indiana; and Division of Clinical Pharmacology and Innovative Therapeutics, the Children’s Mercy Hospital and Clinics, Kansas City, Missouri (A.G.)
Yunlong Liu
Department of Medicine, Division of Clinical Pharmacology (A.R., S.P., Z.D., D.A.F., T.C.S.), and Department of Medical and Molecular Genetics (A.R., Y.L., H.L., C.G., L.L.), Indiana University School of Medicine, Indianapolis, Indiana; and Division of Clinical Pharmacology and Innovative Therapeutics, the Children’s Mercy Hospital and Clinics, Kansas City, Missouri (A.G.)
Santosh Philips
Department of Medicine, Division of Clinical Pharmacology (A.R., S.P., Z.D., D.A.F., T.C.S.), and Department of Medical and Molecular Genetics (A.R., Y.L., H.L., C.G., L.L.), Indiana University School of Medicine, Indianapolis, Indiana; and Division of Clinical Pharmacology and Innovative Therapeutics, the Children’s Mercy Hospital and Clinics, Kansas City, Missouri (A.G.)
Zeruesenay Desta
Department of Medicine, Division of Clinical Pharmacology (A.R., S.P., Z.D., D.A.F., T.C.S.), and Department of Medical and Molecular Genetics (A.R., Y.L., H.L., C.G., L.L.), Indiana University School of Medicine, Indianapolis, Indiana; and Division of Clinical Pharmacology and Innovative Therapeutics, the Children’s Mercy Hospital and Clinics, Kansas City, Missouri (A.G.)
Hai Lin
Department of Medicine, Division of Clinical Pharmacology (A.R., S.P., Z.D., D.A.F., T.C.S.), and Department of Medical and Molecular Genetics (A.R., Y.L., H.L., C.G., L.L.), Indiana University School of Medicine, Indianapolis, Indiana; and Division of Clinical Pharmacology and Innovative Therapeutics, the Children’s Mercy Hospital and Clinics, Kansas City, Missouri (A.G.)
Chirayu Goswami
Department of Medicine, Division of Clinical Pharmacology (A.R., S.P., Z.D., D.A.F., T.C.S.), and Department of Medical and Molecular Genetics (A.R., Y.L., H.L., C.G., L.L.), Indiana University School of Medicine, Indianapolis, Indiana; and Division of Clinical Pharmacology and Innovative Therapeutics, the Children’s Mercy Hospital and Clinics, Kansas City, Missouri (A.G.)
Andrea Gaedigk
Department of Medicine, Division of Clinical Pharmacology (A.R., S.P., Z.D., D.A.F., T.C.S.), and Department of Medical and Molecular Genetics (A.R., Y.L., H.L., C.G., L.L.), Indiana University School of Medicine, Indianapolis, Indiana; and Division of Clinical Pharmacology and Innovative Therapeutics, the Children’s Mercy Hospital and Clinics, Kansas City, Missouri (A.G.)
Lang Li
Department of Medicine, Division of Clinical Pharmacology (A.R., S.P., Z.D., D.A.F., T.C.S.), and Department of Medical and Molecular Genetics (A.R., Y.L., H.L., C.G., L.L.), Indiana University School of Medicine, Indianapolis, Indiana; and Division of Clinical Pharmacology and Innovative Therapeutics, the Children’s Mercy Hospital and Clinics, Kansas City, Missouri (A.G.)
David A. Flockhart
Department of Medicine, Division of Clinical Pharmacology (A.R., S.P., Z.D., D.A.F., T.C.S.), and Department of Medical and Molecular Genetics (A.R., Y.L., H.L., C.G., L.L.), Indiana University School of Medicine, Indianapolis, Indiana; and Division of Clinical Pharmacology and Innovative Therapeutics, the Children’s Mercy Hospital and Clinics, Kansas City, Missouri (A.G.)
Todd C. Skaar
Department of Medicine, Division of Clinical Pharmacology (A.R., S.P., Z.D., D.A.F., T.C.S.), and Department of Medical and Molecular Genetics (A.R., Y.L., H.L., C.G., L.L.), Indiana University School of Medicine, Indianapolis, Indiana; and Division of Clinical Pharmacology and Innovative Therapeutics, the Children’s Mercy Hospital and Clinics, Kansas City, Missouri (A.G.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleSpecial Section on Epigenetic Regulation of Drug Metabolizing Enzymes and Transporters
Rifampin Regulation of miRNAs
Anuradha Ramamoorthy, Yunlong Liu, Santosh Philips, Zeruesenay Desta, Hai Lin, Chirayu Goswami, Andrea Gaedigk, Lang Li, David A. Flockhart and Todd C. Skaar
Drug Metabolism and Disposition October 1, 2013, 41 (10) 1763-1768; DOI: https://doi.org/10.1124/dmd.113.052886
Research ArticleSpecial Section on Epigenetic Regulation of Drug Metabolizing Enzymes and Transporters
Rifampin Regulation of miRNAs
Anuradha Ramamoorthy, Yunlong Liu, Santosh Philips, Zeruesenay Desta, Hai Lin, Chirayu Goswami, Andrea Gaedigk, Lang Li, David A. Flockhart and Todd C. Skaar
Drug Metabolism and Disposition October 1, 2013, 41 (10) 1763-1768; DOI: https://doi.org/10.1124/dmd.113.052886
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement